News about 'TB News'

The Wall Street Journal Health Blog reported that the FDA issued a draft guidance for the drug industry “designed to encourage companies to work in tandem to develop two or more new drugs to be used in combination to treat cancer and infectious diseases, among other illnesses.” This is exciting...

Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci U S A. 2010 Dec 6. [Epub ahead of print] On the early drug discovery front, this study may provide researchers additional areas to target for...

WHO Press Conference Yesterday, Mario Raviglione , Director of Stop TB, and Giorgio Roscigno, CEO of FIND, held a global press conference announcing the World Health Organization’s endorsement of the new rapid diagnostic test Xpert MTB/RIF. If implemented to scale in countries where tuberculosis (...

New WHO Guidelines On World AIDS day, the WHO Department of HIV/AIDS and the Stop TB Department issued new guidelines showing how people with HIV can be protected from tuberculosis with regular and low-cost preventive medication. This holds great promise for people living with HIV because TB is...

WHO 2010 TB Control Report 11 November 2010 – The World Health Organizaton today issued its most comprehensive report ever on the progress being made in combating the tuberculosis (TB) epidemic. The publication contains the very latest data, and for the first time also includes online profiles from...

SABC Story on NC001 The clinical trial of the first novel regimen was featured today on SABC TV in South Africa. This is the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001). The experimental regimen undergoing testing in this trial...

NC001 Today, the TB Alliance announced the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001).The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an...

This post originally appeared on Science Speaks . US Food and Drug Administration The U.S. Food and Drug Administration (FDA) announced $2.9 million to support six research projects related to the diagnosis, treatment and prevention of tuberculosis on Monday. This investment is a component of the...

Dear readers, please accept our apologies for missing the past couple of Tuesday R&D posts on the latest developments and meetings taking place in the TB R&D arena. There have been several important changes afoot and we are in the process of hammering out the final details so things will be...

This story originally appeared on BBC News. Click here to view . By Neil Bowdler Science reporter, BBC News A coloured micrograph of a cross-section of the tuberculosis bacteria Scientists in the UK say they have devised a new ultra-sensitive test which can diagnose the presence of the tuberculosis...

A distinct whole-blood 86-gene transcriptional signature of active TB (Figure 2 in the paper) Last week, a paper was published in Nature by Matthew Berry, Christine Graham et al. which received a fair amount of notice. The authors presented data identifying a probable TB gene signature in people...

This story originally appeared on Reuters here: http://www.reuters.com/article/idUSTRE67H3OH20100818 A patient who tested positive for extreme drug resistant tuberculosis (XDR-TB) awaits treatment at a rural hospital at Tugela Ferry in South Africa's impoverished KwaZulu Natal province, in this...

Originally posted on DailyFinance: http://srph.it/d7qPd8 . AOL Daily Finance GlaxoSmithKline ( GSK ) researchers announced Wednesday that they have found a new compound that may help in the fight against drug-resistant bacteria. The findings could ultimately assist scientists in developing new...

(photo: http://www.musc.edu/chp/papem ) The route of drug delivery for TB drugs is an interesting one with the usual (and valuable) room for debate about different methods. While the standard mode of delivery for most drugs is oral, there is ongoing discussion as to whether aerosol delivery of TB...

TAG 2010 Pipeline Report Treatment Action Group (TAG) recently released their TAG 2010 Pipeline Report (.pdf – 1,700kb), an annual report that explores the progress and overall state of drug development in the fields of HIV, Tuberculosis, and Viral Hepatitis. The report covers the development of...